Skip to main content

Table 3 Hemodynamic data

From: Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up

  No-RHC-PH (n = 5) SSc-ILD-PH (n = 2) SSc-PH Group 2 SSc-PAH (n = 11) SSc-PAH# (Bo-PAH) (n = 5) P value (ANOVA)
mPAP mmHg (SD) 18 (2.00) 48.5 (28.99) 33.0 (4.24) 32.8 (13.31) 22.6 (1.34) 0.03 (F = 3.32)
PAWP mmHg (SD) 11.6 (5.12) 13.5 (2.51) 15.5 (9.19) 13.4 (2.94) 13.2 (3.70) 0.80 (F = 0.41)
PVRi WU (SD) 2.05 (1.04) 34.3 (24.47) 3.11 (0) 6.03 (4.73) 2.66 (0.91) 0.003 (F = 9.26)
RA mmHg (SD) 2.6 (1.51) 8.5 (2.12) 9.0 (0) 10.6 (8.26) 5.4 (1.14) 0.18 (F = 1.72)
TGP mmHg (SD) 6.4 (5.22) 33.0 (19.79) 14.0 (2.82) 27.83 (12.23) 9.4 (3.43) 0.004 (F = 5.990)
  1. mPAP mean pulmonary arterial pressure, PVRi peripheral vascular resistance index, PAWP pulmonary capillary wedge pressure, RA right atrium, SD standard deviation, WU Woods unit, TGP transpulmonary pressure gradient
  2. Obs.: # subgroup of all patients with SSc PAH and mPAP > 20 mmHg—< 25 mmHg, lately named bordeline (Bo-PAH)